TWIST1 and nasopharyngeal carcinoma: Overall, these results demonstrated that aberrantly upregulated Twist1 expression was associated with poor prognosis, tumor migration and invasion, thus Twist1 could be prognostic biomarkers and potential therapy targets for NPC patients.